Orlando, FL-based nScrypt has partnered with the U.S. Military, the Uniformed Services University 4D Bio3 Program, RoosterBio, Inc, and The Geneva Foundation to move bioprinting out of sterile biology laboratories to forward-deployed military positions. For this project, nScrypt has customized its BioAssembly Tool (BAT) bioprinter, which won the 2003 R&D 100 award and is scheduled
CIRCULOGENE molecular diagnostics laboratory, a subcontractor to The Geneva Foundation (Geneva), which has been awarded a $1.5 million U.S. Department of Defense grant, is to develop liquid biopsy markers for the rapid and accurate assessment of traumatic brain injury (TBI). The Defense Medical Research and Development Program (DMRDP) Precision Trauma Care Research Award (PTCRA) is
The Geneva Foundation (Geneva) is honored to announce the 2018 Researcher of the Year award recipient. Senior Nurse Scientist MAJ (Ret.) Mary McCarthy, PhD was selected as Geneva’s 2018 Researcher of the Year in recognition of her longstanding commitment to and excellence in military nursing research, with notable contributions in research quality and research mentorship.
In Spring 2019, the LT Murray Family Foundation, a charitable organization based in Washington state that primarily supports programs in the Puget Sound area, made a generous contribution to The Geneva Foundation (Geneva) in support of the first small grant competition for researchers at Joint Base Lewis-McChord (JBLM). Throughout April, Geneva received ten competitive applications
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) today announced that, for the first time, the U.S. Food and Drug Administration (FDA) has provided formal regulatory agreement for use of an animal model to support development of a drug candidate, remdesivir, for treating deadly Ebola virus (EBOV) infections. This agreement was made possible
The Uniformed Services University (USU) recently issued a Cooperative Agreement to The Geneva Foundation (Geneva) for $2.2M to investigate the efficacy of antimicrobial Blue light therapies (aBL) at combating infections at the implant site for osseointegrated (OI) implant technology. This program was funded by Defense Health Agency (DHA) with partnerships from USU, Geneva, The Wellman
The Uniformed Services University of the Health Sciences (USU) recently issued a cooperative agreement to The Geneva Foundation (Geneva) to facilitate the execution of the Collaboratory for Musculoskeletal Injury Rehabilitation Research (CMIRR). CMIRR is a four-year, $15M program funded by the Defense Health Agency (DHA), with the purpose of improving our rehabilitative approach to caring
Jonas Nursing and Veterans Healthcare and The Geneva Foundation have announced the recipients of a joint scholarship – two doctoral nursing candidates seeking to improve healthcare for veterans and military personnel. This marks the second time since 2016 that the organizations have partnered to award scholarships in support of their shared causes. Ph.D. candidates Lisa